11/21/2023 0 Comments Agena massarray covidAgena’s MassARRAY SARS-CoV-2 Panel kits and instruments are ready for immediate deployment, and we are equipped to supply millions of tests each month. “Agena proactively sourced and secured materials to provide uninterrupted product availability to our customers. The molecular diagnostics company is engaged in development, manufacturing and supplying genetic analysis systems and reagents.Īgena Bioscience technology and operations senior vice president Jason Halsey said: “The unique characteristics of the Agena detection technology provide significant supply chain advantages. The authorisation is expected to address the material shortages and enable laboratories to accelerate testing regardless of instrument or reagent availability.Īlso, the clinical laboratories will be able to process few thousands of samples per day, at a price of less than $10 per sample running the assay on a single MassARRAY instrument, said the company.Īgena Bioscience claimed that its new MassARRAY SARS-CoV-2 Panel is one of the few highest throughput SARS-CoV-2 tests, to receive FDA EUA. MassARRAY SARS-CoV-2 Panel is a high throughput Covid-19 test The genotypes are detected using matrix-assisted laser. Most real time qPCR-based assays target only two or three targets on the viral genome.” The primers of the above-mentioned 17 SNPs used for MassARRAY were designed with Assay Design Suite software (Agena Bioscinece) (Table 5). SAN DIEGO and IRVINE, Calif., Ap/PRNewswire/ - Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products to researchers developing liquid biopsy. The MassARRAY System is the perfect tool for that.”Īgena Bioscience scientific affairs vice president Darryl Irwin said: “The MassARRAY SARS-CoV-2 Panel is the only assay on the market with 5 viral genome targets multiplexed into a single reaction, making it robust against potential mutations arising in the viral genome. nRichDX Revolution Sample Prep System for cfDNA Extraction and Agena's MassARRAY Platform for Detection of Rare Liquid Biopsy Analytes. To address the crisis presented by COVID-19, labs need to cost-effectively process large numbers of samples. (Genomica, Madrid, Spain), HPV MassArray assay (Agena Bioscience, Hamburg, Germany), INNO-LiPA Genotyping Extra II test (FujiriBio Europe,Ghent, Belgium), Venus HPV (Liferiver, Shanghai, China) and Papilloplex HPV assay (Genefirst, Oxford, UK). ![]() MassARRAY instrument is used in fields including cancer profiling, solid tumours and liquid biopsies, inherited genetic disease testing, pharmacogenetics, agricultural genomics, and clinical research, said the company.Īgena Bioscience CEO Peter Dansky said: “Agena is proud to offer a truly scalable platform to support the increasing demand for high-throughput SARS-CoV-2 testing. The assay runs on a single MassARRAY instrument, a high-sensitive mass spectrometry-based platform used for high-throughput genetic analysis. The single-reaction panel is designed to target five regions of the viral genome and delivers enhanced accuracy and sensitivity. Agena Bioscience has secured the US Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for its MassARRAY SARS-CoV-2 Panel to detect coronavirus.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |